Fgf21 stimulates glucose uptake in adipocytes, improves insulin sensitivity and glycemic control, enhances BAT thermogenesis and ameliorates dyslipidemia [80,83], so its overexpression in L-HFD animals may represent an attempt to overcome the metabolic derangements. The gene discussed is INS; the disease is metabolic syndrome.